The core targets between estrogen and AS are PTGS2, SRC, ESR1, and CYP19A1, and the core targets between estrogen and NAFLD are ESR1, PTGS2, and cannabinoid receptor 1 (CNR1). This evidence concerns the gene PTGS2 and metabolic dysfunction-associated steatotic liver disease.